HAVCR2 and acute myeloid leukemia: Methods: Bone marrow (BM) samples from 92 newly diagnosed AML patients at our clinical center (JUN-dataset) were analyzed to detect the expression levels of BATF, EGR1, programmed cell death 1 (PD-1), programmed death-ligand 1 (PD-L1), T cell immunoglobulin and mucin domain-containing protein 3 (TIM3) together with conducting a prognostic assessment.